Antimicrobial Resistance in ESKAPE Pathogens.
Antimicrobial Resistance in ESKAPE Pathogens.
Clin Microbiol Rev. 2020 Jun 17;33(3):
Authors: De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ
Abstract
SUMMARYAntimicrobial-resistant ESKAPE ( Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens represent a global threat to human health. The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options for serious infections, increased the burden of disease, and increased death rates due to treatment failure and requires a coordinated global response for antimicrobial resistance surveillance. This looming health threat has restimulated interest in the development of new antimicrobial therapies, has demanded the need for better patient care, and has facilitated heightened governance over stewardship practices.
PMID: 32404435 [PubMed - in process]
Source: Clinical Microbiology Reviews - Category: Microbiology Authors: De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ Tags: Clin Microbiol Rev Source Type: research
More News: Acinetobacter | Antibiotic Therapy | Antimicrobial Resistance | Enterococcus | Genetics | Microbiology | Staphylococcus Aureus